Roper Technologies

Roper Technologies

Yahoo Finance • 2 days ago

Shopify upgraded, PepsiCo downgrade: Wall Street's top analyst calls

Shopify upgraded, PepsiCo downgrade: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled... Full story

Yahoo Finance • 3 days ago

DAT: Dry van spot rates top contract for first time since February 2022; flatbed rates hit record high

DAT SolutionsDry van spot rates top contract for first time since February 2022; flatbed rates hit record high PORTLAND, Ore., July 09, 2026 (GLOBE NEWSWIRE) -- Truckload rates climbed faster than freight volumes last month, a disparity t... Full story

Yahoo Finance • 5 days ago

Trimble shares get upward bump on report it may sell transportation unit

Shares of Trimble made a small upward move Tuesday on the back of a report the company may be selling its Transportation & Logistics (T&L) segment. Axios reported Tuesday that Trimble was working with Goldman Sachs to sell the unit that i... Full story

Yahoo Finance • 11 days ago

Roche (SWX:ROP) Stock May Still Be A Bargain On A 32% Run

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Roche Holding stock has delivered a 31.7% return over the past three years, and the current valu... Full story

Yahoo Finance • 11 days ago

Roper Technologies schedules second quarter 2026 financial results conference call

SARASOTA, Fla., July 01, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that its financial results for the second quarter of 2026, ended June 30, 2026, will be released before the market opens on Thursday, July... Full story

Yahoo Finance • 12 days ago

FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)

The filing application is based on improvements seen across key efficacy endpoints from the global Phase III SatraGO-1 and SatraGO-2 studies, including proptosis (bulging eyes) and diplopia (double vision) in active TED Enspryng (satralizu... Full story

Yahoo Finance • 12 days ago

FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)

The filing application is based on improvements seen across key efficacy endpoints from the global phase III SatraGO-1 and SatraGO-2 studies, including proptosis (bulging eyes) and diplopia (double vision) in active TEDEnspryng (satralizum... Full story

Yahoo Finance • 19 days ago

Roche (SWX:ROP) Wins Key Cancer Drug And Diagnostic FDA Milestones

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Roche Holding received FDA acceptance of Lunsumio VELO plus Polivy for relapsed or refractory large B cell lymphoma based on phase... Full story

Yahoo Finance • 26 days ago

DAT: Spot truckload rates rise in May on capacity pressure across the market

PORTLAND, Ore., June 16, 2026 (GLOBE NEWSWIRE) -- Truckload spot rates moved higher in May even as freight volumes fell, according to DAT Freight & Analytics, provider of the industry’s leading load boards and freight analytics. Several... Full story

Yahoo Finance • 29 days ago

Roche Oncology Milestones Spark Fresh Look At Valuation And Growth Potential

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Roche Holding received U.S. FDA Priority Review for Tecentriq plus chemotherapy as a potential adjuvant treatment for stage... Full story

Yahoo Finance • 30 days ago

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

F. Hoffmann-La Roche Ltd The new VENTANA PTEN (SP218) RxDx Assay fulfils an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP In prostate cancer, PTEN... Full story

Yahoo Finance • last month

What Makes Roper (ROP) an Attractive Bet?

Dodge & Cox Fund, an investment management company, released its first-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. A copy of the letter is available to download here. U.S. equities declined broadly in Q1 2026, with the S&P... Full story

Yahoo Finance • last month

Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection

New Roche test targeting detection of Bundibugyo virus supports efforts to address critical need during ongoing outbreaks1 Roche's unique outbreak response capabilities enabled rapid development of the PCR test within six days of the Bundi... Full story

Yahoo Finance • last month

Roper Technologies, Inc. (ROP) Announces Dividend of $0.91 Per Share

Roper Technologies, Inc. (NASDAQ:ROP) is among the 10 Most Oversold S&P 500 Stocks So Far in 2026. On May 19, the company said that its Board of Directors had approved a dividend of $0.91 per share.Roper Technologies, Inc. (ROP) Announces... Full story

Yahoo Finance • 2 months ago

Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management

F. Hoffmann-La Roche Ltd Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO—a certified algorithm developed by t... Full story

Yahoo Finance • 2 months ago

What to Know About This Fund's $28 Million SaaS Stock Exit After a 15% Decline

Wishbone Management reported a full exit from Lightspeed Commerce(NYSE:LSPD) as of its May 14, 2026, SEC filing, with an estimated $27.96 million sale based on quarterly average pricing. What happened According to a May 14, 2026, SEC fil... Full story

Yahoo Finance • 2 months ago

Roche Breast Cancer Data At ASCO 2026 Tests Pipeline Narrative

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Roche Holding (SWX:ROP) and its subsidiary Genentech are presenting new breast cancer data at the ASCO 2026 Annual Meeting.... Full story

Yahoo Finance • 2 months ago

Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer

F. Hoffmann-La Roche Ltd New giredestrant data from the lidERA study on its potential as a new standard of care for adjuvant ER-positive breast cancer across all menopausal stages Primary results from the persevERA study on the numerical... Full story

Yahoo Finance • 2 months ago

DAT: Higher fuel costs lifted April truckload rates; freight volumes eased

DAT Solutions Spot Market Volume & Rates: VanHigher fuel costs lifted April truckload rates; freight volumes eased·GlobeNewswire Inc. PORTLAND, Ore., May 18, 2026 (GLOBE NEWSWIRE) -- Truckload spot and contract rates climbed sharply in A... Full story

Yahoo Finance • 2 months ago

Jeremy Grantham's Strategic Moves: A Closer Look at Wells Fargo & Co

This article first appeared on GuruFocus. Insights from the First Quarter of 2026 Jeremy Grantham (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2026, providing insights into his investment moves during th... Full story